Tg Therapeutics (TGTX) Leases (2019 - 2025)
Tg Therapeutics (TGTX) has 7 years of Leases data on record, last reported at $6.3 million in Q4 2025.
- For Q4 2025, Leases fell 11.9% year-over-year to $6.3 million; the TTM value through Dec 2025 reached $6.3 million, down 11.9%, while the annual FY2025 figure was $6.3 million, 11.9% down from the prior year.
- Leases reached $6.3 million in Q4 2025 per TGTX's latest filing, down from $6.5 million in the prior quarter.
- Across five years, Leases topped out at $9.1 million in Q1 2021 and bottomed at $6.3 million in Q4 2025.
- Average Leases over 5 years is $8.1 million, with a median of $8.4 million recorded in 2023.
- Peak YoY movement for Leases: increased 3.12% in 2022, then dropped 12.38% in 2025.
- A 5-year view of Leases shows it stood at $8.6 million in 2021, then grew by 3.0% to $8.9 million in 2022, then fell by 9.43% to $8.0 million in 2023, then dropped by 11.17% to $7.2 million in 2024, then dropped by 11.9% to $6.3 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $6.3 million in Q4 2025, $6.5 million in Q3 2025, and $6.7 million in Q2 2025.